Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients

American Journal of Nephrology

Volumn 28, Issue 1, 2007, Pages 91-96

  Kocak, H ^a   Gumuslu, S ^a   Ermis, C ^a   Mahsereci, E ^a   Sahin, E ^a   Gocmen, A Y ^a   Ersoy, F ^a   Suleymanlar, G ^a   Yakupoglu, G ^a   Tuncer, M ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Asymmetric dimethylarginine; Carotid intima media thickness; Oxidative stress; Peritoneal dialysis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED OXIDATION PROTEIN PRODUCT; MALONALDEHYDE; N(G),N(G) DIMETHYLARGININE; PENTOSIDINE; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADULT; ARGININE; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUNICA INTIMA;

EID: 36248944182     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109397     Document Type: Article

References (27)

1. Locatelli F, Marcelli D, Conte F, et al: Cardiovascular disease in chronic renal failure: the challenge continues. Registro Lombardo Dialisi e Trapianto. Nephrol Dial Transplant 2000;15(suppl 5):69-80.
2. Becker BN, Himmelfarb J, Henrich WL, Hakim RM: Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 1997;8:475-486.
3. Menon V, Gul A, Sarnak MJ: Cardiovascular risk factors in chronic kidney disease. Kidney Int 2005;68:1413-1418.
4. Himmelfarb J, Hakim RM: Oxidative stress in uremia. Curr Opin Nephrol Hypertens 2003;12:593-598.
5. Himmelfarb J, Ikizler TA, Stenvinkel P, Hakim RM: The elephant in uremia: reflections on oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-1538.
6. Zoccali C, Mallamaci F, Tripepi G: Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl 2003;(85):S105-S110.
7. Craven TE, Ryu JE, Espeland MA, et al: Evaluation of the association between carotid artery atherosclerosis and coronary artery stenosis: a case control study. Circulation 1990;82:1230-1242.
8. Salonen R, Salonen JT: Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis 1990;81:33-40.
9. Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Malmejac A, Guize L: Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb 1991;11:966-972.
10. Ohkuma T, Minagawa T, Takada N, Ohno M, Oda H, Ohashi H: C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis 2003;42:355-361.
11. Papagianni A, Kokolina E, Kalovoulos M, Vainas A, Dimitriadis C, Memmos D: Carotid atherosclerosis is associated with inflammation, malnutrition and intracellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2004;19:1258-1263.
12. Aminbakhsh A, Mancini GB: Carotid intima media thickness measurements. What defines an abnormality? A systematic review. Clin Invest Med 1999;22:149-157.
13. Henle T, Deppisch R, Beck W, Hergesell O, Hansch GM, Ritz E: Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. Nephrol Dial Transplant 1999;14:1968-1975.
14. Witko Sarsat V, Friedlander M, Capeillere-Blandin C, et al: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304-1313.
15. Kalousova M, Zima T, Tesar V, Lachmanova J: Advanced glycation end products and advanced oxidation protein products in hemodialyzed patients. Blood Purif 2002;20:531-536.
16. Gugliucci A, Menini T: Circulating advanced glycation peptides in streptozotocin-induced diabetic rats: evidence for preferential modification of IgG light chains. Life Sci 1998;62:2141-2150.
17. Wasowicz W, Neve J, Peretz A: Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993;39:2522-2526.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
19. Pawlak K , Pawlak D, Brzosko S, Mysliwiec M: Carotid atherosclerosis is associated with enhanced β-chemokine levels in patients on continuous ambulatory peritoneal dialysis. Atherosclerosis 2006;186:146-151.
20. Taylor JE, Scott N, Bridges A Henderson IS, Stewart WK, Belch JJ: Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients. Perit Dial Int 1992;12:252-256.
21. Canestrari F, Buoncristiani U, Galli F, et al: Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients. Clin Chim Acta 1995;234:127-136.
22. Vaziri ND: Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 2004;13:93-99.
23. Raj DS, Choudhury D, Welbourne TC, Levi M: Advanced glycation end products: a nephrologist's perspective. Am J Kidney Dis 2000;35:365-380.
24. Ateshkadi A, Johnson CA, Founds HW, Zimmerman SW: Serum advanced glycosylation end-products in patients on hemodialysis and CAPD. Perit Dial Int 1995;15:129-133.
25. Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF 2nd, Kullo IJ: Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 2007;20:83-89.
26. Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, Jeon JS, Ha H, Lee HB: Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 2006;69:2022-2028.
27. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C: Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272-1280.